NCT03514940

Brief Summary

fetal gastro intestinal abnormalities can be accurately diagnosed in second trimester

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
130

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2018

Completed
10 days until next milestone

Study Start

First participant enrolled

May 2, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 3, 2018

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 3, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 7, 2020

Completed
Last Updated

January 27, 2020

Status Verified

January 1, 2020

Enrollment Period

2.1 years

First QC Date

April 22, 2018

Last Update Submit

January 24, 2020

Conditions

Fetal Anomalies

Outcome Measures

Primary Outcomes (1)

  • The number of participants who will be diagnosed to have GIT anomalies

    GIT anomalies that will be diagnosed by US and confirmed postnatal and managed operatively

    within 5 moths

Interventions

ultrasoundDIAGNOSTIC_TEST

second trimester us scan will be made to pregnant women

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspregnant females
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

pregnant ladies either primi or multigravida

You may qualify if:

  • pregnant women either primi or multigravida
  • pregnant in 18- 24 weeks

You may not qualify if:

  • first trimester pregnant ladies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Algazeerah

Giza, Egypt

RECRUITING

MeSH Terms

Conditions

Congenital Abnormalities

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Mahmoud Alalfy, M.s.c

    Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mahmoud Alalfy

CONTACT

01002611058mahmoudalalfy@ymail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Researcher , National Research centre and Specialist of Obstetrics and Gynecology in Aljazeerah hospital

Study Record Dates

First Submitted

April 22, 2018

First Posted

May 3, 2018

Study Start

May 2, 2018

Primary Completion

June 3, 2020

Study Completion

July 7, 2020

Last Updated

January 27, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

results will be published

Locations

EG(1)